Alvotech
Teva and Alvotech face FDA rejection for Stelara biosimilar after Humira setbacks
Anika Sharma
Ongoing issues at the Alvotech manufacturing facility in Reykjavik have led to yet another FDA rejection, this time affecting the ...
Alvotech Seeks Interchangeability Status for Humira Biosimilar Again
Anika Sharma
Alvotech is forging an audacious path towards a potential game-changer. CEO Robert Wessman recently unveiled a resubmission of their Biologics ...
Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight
SG Tylor
Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...
Another Stelara patent settlement was reached by J&J, this time with Alvotech and Teva
SG Tylor
Source – Johnson & Johnson By early 2025, a new settlement may allow for the entry of a second biosimilar ...
